PTC Therapeutics, Inc. (BH3)
Market Open
20 Jul, 12:34
XSTU 
€
68. 70
+0.14
+0.2042%
€
- Market Cap
- P/E Ratio
- Div Yield
150 Volume
-5.84 Eps
€ 68.56
Previous Close Want to track BH3 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
| Name | Time | Cons. EPS | Eps |
|---|---|---|---|
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
BH3 Earnings Reports FAQ
What is the earnings per share (EPS) for BH3?
The current EPS is -5.84.
What is the company's earnings growth rate?
PTC Therapeutics, Inc has not announced its next earnings release date. You can monitor upcoming announcements in Marketlog's earnings calendar or in the company profile.
When is the next earnings release date?
PTC Therapeutics, Inc has not announced its next earnings release date.
What were the most recent quarterly earnings?
The most recent quarterly earnings for PTC Therapeutics, Inc are not available at this time.
What is the price-to-earnings (P/E) ratio?
There is no P/E ratio for BH3 at this time, as PTC Therapeutics, Inc has no recent EPS data to calculate it.
